HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6- (bromomethylene)tetrahydro- 3- (1- naphthaleneyl)- 2H- pyran- 2- one

structure given in first source; potent irreversible, mechanism-based inhibitor of myocardial calcium-independent phospholipase A2
Also Known As:
6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one; 6-BTNPO; HELSS; bromoenol lactone
Networked: 26 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Turk, John: 5 articles (07/2012 - 02/2004)
2. Bao, Shunzhong: 4 articles (01/2009 - 02/2004)
3. Zhang, Sheng: 3 articles (07/2011 - 02/2004)
4. Ramanadham, Sasanka: 3 articles (02/2005 - 02/2004)
5. Farooqui, Akhlaq A: 2 articles (06/2015 - 11/2004)
6. Ong, Wei-Yi: 2 articles (06/2015 - 11/2004)
7. Liu, Shu: 2 articles (01/2015 - 07/2012)
8. Jin, Chun: 2 articles (02/2004 - 02/2004)
9. Ma, Zhongmin: 2 articles (02/2004 - 02/2004)
10. Ford, D A: 2 articles (07/2001 - 10/2000)

Related Diseases

1. Hyperalgesia
2. Schizophrenia (Dementia Praecox)
3. Tardive Dyskinesia
4. Ischemia
5. Insulinoma

Related Drugs and Biologics

1. Calcium-Independent Phospholipases A2
2. arachidonyltrifluoromethane
3. Antisense Oligonucleotides
4. Carrageenan
5. Secretory Phospholipases A2
6. Phospholipases A2 (Phospholipase A2)
7. Protein Isoforms (Isoforms)
8. Enzymes
9. Phospholipases (Phospholipase)
10. Calcium

Related Therapies and Procedures

1. Ligation
2. Spinal Injections
3. Intraperitoneal Injections